Edge Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
WA
PCM
YIH
DT
MFG
GI
NWAG
Edge Wealth Management's ADPT Position: Q2 2026 in Review
Edge Wealth Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 90,000 shares worth $1.93M. The position accounts for 0.33% of the portfolio, ranked #32.
Edge Wealth Management first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.3M in Q4 2020. 22 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Edge Wealth Management held 90,000 shares of Adaptive Biotechnologies worth $1.93M as of Q2 2026.
- Edge Wealth Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
- Adaptive Biotechnologies made up 0.33% of Edge Wealth Management's portfolio in Q2 2026, its #32 holding.
- Edge Wealth Management first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
- Edge Wealth Management's Adaptive Biotechnologies position peaked at $5.3M in Q4 2020.
- 22 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Edge Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.